<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6780377/results/search/test_trace/results.xml">
  <result pre="importantly, DENV is endemic in 112 countries, and incidence of" exact="infection" post="has risen 30-fold over the last five decades [4]."/>
  <result pre="estimated that ~400 million individuals suffer annually because of DENV" exact="infection" post="[5]. DENV infection results in varying degrees of clinical"/>
  <result pre="million individuals suffer annually because of DENV infection [5]. DENV" exact="infection" post="results in varying degrees of clinical signs and symptoms"/>
  <result pre="before the 18th century; however, the actual causes of dengue" exact="infection" post="remained unknown until 1906 [12]. In 1907, Ashburn and"/>
  <result pre="From 1943 to 1944, a major breakthrough occurred in the" exact="treatment" post="of dengue fever, when Dr. R. Kimura (Japan) and"/>
  <result pre="through mucocutaneous exposure, and through bone marrow transplants [24]. DENV" exact="infection" post="of healthcare workers usually occurs as a result of"/>
  <result pre="and pre-existing immunity to one serotype does not defend against" exact="infection" post="with other serotypes, as some serotypes are more virulent"/>
  <result pre="that glycolysis inhibition through sodium oxamate and 2-deoxy- d-glucose (2DG)" exact="treatment" post="can result in a significant reduction in DENV replication"/>
  <result pre="of the envelope but is also needed for inducing viral" exact="infection" post="in many ways. Replication includes virion egress and assembly"/>
  <result pre="which was first identified through the DENV-2 replicon mediated siRNA" exact="screening" post="[60,62]. Lipophagy is known as a type of selective"/>
  <result pre="that transports lipids for β-oxidation. Several studies indicate that DENV" exact="infection" post="induces pro-viral autophagy [62,63,64,65,66]. The lipids accumulated in auto-phagosomes"/>
  <result pre="(GSLs), chaperone-proteins, and undefined proteins have been reported as potential" exact="treatment" post="candidates. Targeting host factors involved in DENV attachment can"/>
  <result pre="1), were found to act as strong inhibitors of DENV" exact="infection" post="in DC-transfected cells. These findings can potentially be utilized"/>
  <result pre="virus [94]. DENV uses two pathways to enter DCs, whereby" exact="infection" post="can enter immature DCs through DC-SIGN, or through Fc"/>
  <result pre="antiviral therapeutics [99]. However, the potential of such compounds for" exact="screening" post="purposes is tremendous. The host proteins are potential antiviral"/>
  <result pre="α-glucosidase inhibitor celgosivir has been shown to inhibit DENV, and" exact="treatment" post="with celgosivir have shown to causing an improved survival"/>
  <result pre="decrease mortality in an &quot;antibody-dependent enhancement&quot; model of secondary DENV" exact="infection" post="[117]. It is also noteworthy that α-glucosidase substrate mimics,"/>
  <result pre="a better understanding of the host immune response during DENV" exact="infection" post="and the evasion mechanisms would have great importance for"/>
  <result pre="domain family 5 member A (CLEC5A) does not block DENV" exact="infection" post="[122]. Other important molecules such as toll-like receptors (TLR3)"/>
  <result pre="rhesus macaques aided in enhanced antiviral mechanisms during primary DENV" exact="infection" post="[127]. Gene expression analysis indicates that RIG-I and MDA5"/>
  <result pre="or single RIG-I/MDA5-deficient fibroblasts triggers both responses [128]. Furthermore, early" exact="detection" post="of antibodies via RNA sensors (for examples RIG-I) enhanced"/>
  <result pre="of antibodies via RNA sensors (for examples RIG-I) enhanced DENV" exact="infection" post="by tissue-resident mast cells that produce type IFN-I, along"/>
  <result pre="Extant evidence (experimented upon mice) further indicates that DENV primary" exact="infection" post="utilizes the interferon α/β receptor (IFNAR)-dependent (including STAT1-dependent and"/>
  <result pre="all of which are responsible for primary and secondary DENV" exact="infection" post="in humans, are excessively elevated and have been reported"/>
  <result pre="production that assists the host in resistance against primary DENV" exact="infection" post="[145], which was previously found to inhibit DENV replication"/>
  <result pre="cytokines TNF-α and MIF during the host response to DENV" exact="infection" post="favors more severe disease [152]. The chemokine system that"/>
  <result pre="chemokine receptor type 3) to improve host resistance against DENV" exact="infection" post="[7]. Clinical studies in endemic areas indicated the presence"/>
  <result pre="CXCR3 expresses protective host responses, but CCR2 and CCR4 cause" exact="infection" post="rather than providing protection against DENV infection [154]. Cellular"/>
  <result pre="and CCR4 cause infection rather than providing protection against DENV" exact="infection" post="[154]. Cellular populations are also important for DENV infection."/>
  <result pre="by stabilization of endothelial cell development is important for DENV" exact="infection" post="prevention [201]. The MIF inhibitor ISO-1 reduces permeability in"/>
  <result pre="release into the cytoplasm. If the early steps of DENV" exact="infection" post="cycle can be blocked by targeting host attachment factors"/>
  <result pre="The inflammatory response is activated in host cells during DENV" exact="infection" post="to clear the pathogen from the host immune system."/>
  <result pre="InfectionTraffic20171821823110.1111/tra.1246928128492 90.FlipseJ.WilschutJ.TrafficJ.S.Molecular mechanisms involved in antibody-dependent enhancement of dengue virus" exact="infection" post="in humansTraffic201314253510.1111/tra.1201222998156 91.LozachP.Y.BurleighL.StaropoliI.Navarro-SanchezE.HarriagueJ.VirelizierJ.L.ReyF.A.DesprèsP.Arenzana-SeisdedosF.AmaraA.Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Non-Integrin"/>
  <result pre="and STAT1-independent pathways in the control of primary dengue virus" exact="infection" post="in miceJ. Immunol.20051753946395410.4049/jimmunol.175.6.394616148142 134.GomesA.L.V.WeeL.J.K.KhanA.M.GilL.H.V.G.MarquesE.T.A.Calzavara-SilvaC.E.TanT.W.Classification of Dengue Fever Patients Based"/>
  <result pre="in VitroJ. Med. Virol.200577899510.1002/jmv.2041816032750 147.GuntherV.J.PutnakR.EckelsK.H.MammenM.P.SchererJ.M.LyonsA.SunW.A human challenge model for dengue" exact="infection" post="reveals a possible protective role for sustained interferon gamma"/>
  <result pre="Asia and West Africa maintained the sylvatic cycle and supported" exact="contact" post="with human populations, leading to an urban endemic/epidemic cycle"/>
  <result pre="and hexokinase II (HK-II), the first enzyme of glycolysis. DENV" exact="infection" post="alters glucose metabolism allosterically by up-regulation of glycolytic enzymes."/>
 </snippets>
</snippetsTree>
